Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Strub

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Theranostics|February 12, 2020
The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies"Thomas Strub, Robert Ballotti, Corine Bertolotto
Cancers|October 14, 2022
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?Imène Krossa, Thomas Strub, Andrew E Aplin, et al.
Progress in Retinal and Eye Research|April 14, 2021
Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncologyThomas Strub, Arnaud Martel, Sacha Nahon-Esteve, et al.
International Journal of Molecular Sciences|June 10, 2022
MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate BalanceMaria Chiara Gelmi, Laurien E Houtzagers, Thomas Strub, et al.
Pigment Cell & Melanoma Research|April 20, 2011
BRCA1 is a new MITF target geneLaurent Beuret, Mickael Ohanna, Thomas Strub, et al.
Plos Genetics|October 7, 2015
Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem CellsDana Koludrovic, Patrick Laurette, Thomas Strub, et al.
Theranostics|June 8, 2022
Recent advances in understanding the role of HES6 in cancersImène Krossa, Thomas Strub, Arnaud Martel, et al.
Cell Death Discovery|April 28, 2020
Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cellsLara Bellini, Thomas Strub, Nadia Habel, et al.
Elife|March 25, 2015
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cellsPatrick Laurette, Thomas Strub, Dana Koludrovic, et al.
Molecular Cancer|January 8, 2021
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicityYann Cheli, Meri K Tulic, Najla El Hachem, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Theranostics|February 12, 2020
The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies"Thomas Strub, Robert Ballotti, Corine Bertolotto
Cancers|October 14, 2022
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?Imène Krossa, Thomas Strub, Andrew E Aplin, et al.
Progress in Retinal and Eye Research|April 14, 2021
Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncologyThomas Strub, Arnaud Martel, Sacha Nahon-Esteve, et al.
International Journal of Molecular Sciences|June 10, 2022
MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate BalanceMaria Chiara Gelmi, Laurien E Houtzagers, Thomas Strub, et al.
Pigment Cell & Melanoma Research|April 20, 2011
BRCA1 is a new MITF target geneLaurent Beuret, Mickael Ohanna, Thomas Strub, et al.
Plos Genetics|October 7, 2015
Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem CellsDana Koludrovic, Patrick Laurette, Thomas Strub, et al.
Theranostics|June 8, 2022
Recent advances in understanding the role of HES6 in cancersImène Krossa, Thomas Strub, Arnaud Martel, et al.
Cell Death Discovery|April 28, 2020
Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cellsLara Bellini, Thomas Strub, Nadia Habel, et al.
Elife|March 25, 2015
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cellsPatrick Laurette, Thomas Strub, Dana Koludrovic, et al.
Molecular Cancer|January 8, 2021
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicityYann Cheli, Meri K Tulic, Najla El Hachem, et al.
Pageof 3